Shiraz E-Medical Journal

Published by: Kowsar

Barriers to Influenza Immunization

Mohsen Moghaddami 1 , * and Mitra Amini 2
Authors Information
1 Health Policy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
2 Quality Improvement in Clinical Education Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
Article information
  • Shiraz E-Medical Journal: August 2017, 18 (8); e55914
  • Published Online: July 26, 2017
  • Article Type: Letter
  • Received: June 20, 2017
  • Revised: July 6, 2017
  • Accepted: July 23, 2017
  • DOI: 10.5812/semj.55914

To Cite: Moghaddami M, Amini M. Barriers to Influenza Immunization, Shiraz E-Med J. 2017 ;18(8):e55914. doi: 10.5812/semj.55914.

Copyright © 2017, Shiraz E-Medical Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
References
  • 1. Kroneman M, van Essen GA, John Paget W. Influenza vaccination coverage and reasons to refrain among high-risk persons in four European countries. Vaccine. 2006; 24(5): 622-8[DOI][PubMed]
  • 2. McDaid D, Maynard A. Translating evidence into practice. The case of influenza vaccination. Eur J Public Health. 2001; 11(4): 453-5[DOI][PubMed]
  • 3. Choi DK, Fuleihan RL, Walterhouse DO. Serologic response and clinical efficacy of influenza vaccination in children and young adults on chemotherapy for cancer. Pediatr Blood Cancer. 2016; 63(11): 2011-8[DOI][PubMed]
  • 4. Treanor JJ. CLINICAL PRACTICE. Influenza Vaccination. N Engl J Med. 2016; 375(13): 1261-8[DOI][PubMed]
  • 5. Vasileiou E, Sheikh A, Butler C, Ferkh K, Simpson CR. P133 Safety and effectiveness of influenza vaccines in people with asthma: a systematic review and meta-analysis. Thorax. 2016; 71: 155.1[DOI]
  • 6. Moradi-Lakeh M, Esteghamati A. National Immunization Program in Iran: whys and why nots. Hum Vaccin Immunother. 2013; 9(1): 112-4[DOI][PubMed]
  • 7. Shokouhi S, Alavi Darazam I, Kardan G. Adult immunization among health care personnel and target groups in Iran. Arch Clin Infect Dis. 2015; 10(1)[DOI]
  • 8. Moghadami M, Moattari A, Tabatabaee HR, Mirahmadizadeh A, Rezaianzadeh A, Hasanzadeh J, et al. High titers of hemagglutination inhibition antibodies against 2009 H1N1 influenza virus in Southern Iran. Iran J Immunol. 2010; 7(1): 39-48[PubMed]
  • 9. Weingarten S, Riedinger M, Bolton LB, Miles P, Ault M. Barriers to influenza vaccine acceptance. A survey of physicians and nurses. Am J Infect Control. 1989; 17(4): 202-7[DOI][PubMed]
  • 10. Hsu DJ, North CM, Brode SK, Celli BR. Identification of Barriers to Influenza Vaccination in Patients with Chronic Obstructive Pulmonary Disease: Analysis of the 2012 Behavioral Risk Factors Surveillance System. Chronic Obstr Pulm Dis. 2016; 3(3): 620-7[DOI][PubMed]
  • 11. Askarian M, Khazaeipour Z, McLaws ML. Influenza vaccination uptake among students and clinical staff of a university in Iran. Int J Infect Dis. 2009; 13(4): 476-82[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments